Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT : a case report
dc.contributor.author | Lawal, Ismaheel Opeyemi | |
dc.contributor.author | Ankrah, Alfred O. | |
dc.contributor.author | Ololade, Kehinde O. | |
dc.contributor.author | Modiselle, Moshe | |
dc.contributor.author | Sathekge, Mike Machaba | |
dc.date.accessioned | 2018-03-15T10:36:40Z | |
dc.date.available | 2018-03-15T10:36:40Z | |
dc.date.issued | 2017-11 | |
dc.description.abstract | RATIONALE : F-18 Fluoro Deoxyglucose positron emission tomography and computed tomography (F-18 FDG PET/CT) is a useful modality in the evaluation of patients with malignancies. Increased incidence of lympho-proliferative disorders has been reported in individuals with long-standing end-stage renal disorders treated with renal replacement therapy. PATIENT CONCERNS : A 30-year-old male on peritoneal dialysis on account of end-stage renal disease. He had acute rejection of an earlier transplanted renal allograft. He was referred for an F-18 FDG PET/CT based on a clinical suspicion of lymphoma on account of bilateral inguinal lymphadenopathy associated with bilateral pedal swelling. DIAGNOSIS : Renal osteodystrophy was diagnosed based on diffusely intense F-18 FDG uptake in the axial skeleton, focal uptake in the costochondrial junctions and linear cortical uptake in the appendicular skeleton. No findings suggestive of lymphoma was seen. INTERVENTIONS : A diagnosis of renal osteodystrophy with no evidence of a lymphoma prevented futile biopsy of inguinal lymphadenopathy. Patient continued with peritoneal dialysis with no further intervention OUTCOMES : Regular follow-up of patient to monitor calcium, phosphate and parathyroid hormone levels. Treatment will be indicated when laboratory results as well as clinical signs and symptoms are suggestive. LESSON : Metabolic bone disorder such as is seen in renal osteodystrophy should be considered in the differential diagnoses in patients with diffusely increased bone uptake on F-18 FDG PET/CT scan. ABBREVIATIONS : CT = computed tomography, DOTANOC = 1-NaI3-octrotide 1,4,7,10-tetraazacyclododecane-N,N’,N”,N”’- tetraacetic acid, F-18 FDG = fluorine-18 2-fluoro-2-deoxyglucose, Ga-68 = gallium 68, HIV = human immunodeficiency virus, MDP = methylene diphosphonate, PET = positron emission tomography, PSMA = prostate specific membrane antigen, PTH = parathyroid hormone, Tc-99m = technetium 99 metastable. | en_ZA |
dc.description.department | Nuclear Medicine | en_ZA |
dc.description.librarian | am2018 | en_ZA |
dc.description.uri | https://journals.lww.com/md-journal/pages/default.aspx | en_ZA |
dc.identifier.citation | Lawal et al. 2017, 'Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: a case report', Medicine, vol. 96, no. 46, pp. 1-3. | en_ZA |
dc.identifier.issn | 0025-7974 (print) | |
dc.identifier.issn | 1536-5964 (online) | |
dc.identifier.other | 10.1097/MD.0000000000008471 | |
dc.identifier.uri | http://hdl.handle.net/2263/64279 | |
dc.language.iso | en | en_ZA |
dc.publisher | Wolters Kluwer Health, Inc. | en_ZA |
dc.rights | © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC). | en_ZA |
dc.subject | Metabolic superscan | en_ZA |
dc.subject | Renal osteodystrophy | en_ZA |
dc.subject | F-18 Fluoro Deoxyglucose positron emission tomography and computed tomography (F-18 FDG PET/CT) | en_ZA |
dc.subject | Adult | en_ZA |
dc.subject | Case report | en_ZA |
dc.subject | Chronic kidney disease-mineral and bone disorder | en_ZA |
dc.subject | Diagnostic imaging | en_ZA |
dc.subject | Male | en_ZA |
dc.subject | Positron emission tomography/computed tomography (PET/CT) | en_ZA |
dc.title | Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT : a case report | en_ZA |
dc.type | Article | en_ZA |